Ufp Technologies (UFPT) Cash & Equivalents (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Cash & Equivalents came in at $9.0 million in Q2 2026, down 39.26% on a YoY basis from $14.9 million in Q2 2025, and down 54.72% quarter-over-quarter from $20.0 million in Q1 2026.
Analysis
Ufp Technologies (UFPT) Cash & Equivalents (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported Cash & Equivalents for 17 consecutive years, with $9.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash & Equivalents fell 39.26% year-over-year to $9.0 million; the trailing twelve-month figure through Jun 2026 stood at $9.0 million (down 39.26% YoY), and the FY2025 full-year result was $20.3 million, up 50.94% from the prior year.
- Cash & Equivalents declined to $9.0 million in Q2 2026 per UFPT's latest filing, from $20.0 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $20.3 million in Q4 2025 and bottomed at $3.7 million in Q1 2022.
- Historically, Cash & Equivalents has averaged $11.2 million across 5 years, with a median of $10.7 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Cash & Equivalents slumped 85.61% in 2022, then jumped 216.16% in 2024.
- Over 5 years, Cash & Equivalents stood at $4.5 million in 2022, then grew by 18.24% to $5.3 million in 2023, then surged by 155.56% to $13.4 million in 2024, then soared by 50.94% to $20.3 million in 2025, then plunged by 55.45% to $9.0 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $9.0 million, $20.0 million, and $20.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.69 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 3.39 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.91 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 1.36 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 1.11 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | 9.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.05 Mn |
| Mar 31, 2026 | 19.98 Mn |
| Dec 31, 2025 | 20.30 Mn |
| Sep 30, 2025 | 18.23 Mn |
| Jun 30, 2025 | 14.89 Mn |
| Mar 31, 2025 | 14.03 Mn |
| Dec 31, 2024 | 13.45 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 16.73 Mn |
| Mar 31, 2024 | 11.37 Mn |
| Dec 31, 2023 | 5.26 Mn |
| Sep 30, 2023 | 6.38 Mn |
| Jun 30, 2023 | 5.29 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 4.45 Mn |
| Sep 30, 2022 | 9.94 Mn |
| Jun 30, 2022 | 5.58 Mn |
| Mar 31, 2022 | 3.65 Mn |
| Sep 30, 2021 | 33.09 Mn |
| Jun 30, 2021 | 30.27 Mn |